Search
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Invitrogen
Teicoplanin Recombinant Mouse Monoclonal Antibody (2F4)
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Teicoplanin Antibody (MA566292) in SDS-PAGE
SDS-PAGE characterization of Teicoplanin under reducing conditions. Lane M: Protein marker (kDa); Lane TCL: Purified Teicoplanin Recombinant Monoclonal (Product # MA566292). Teicoplanin showing heavy chain (~50 kDa) and light chain (~25 kDa). Gels were stained with Coomassie Brilliant Blue R-460.
产品信息
MA566292
产品规格
种属反应
Chemical
宿主/亚型
Mouse
/ IgG
Expression System
CHO cells
分类
Recombinant Monoclonal
类型
Antibody
克隆号
2F4
抗原
Conjugate of TCL hapten and KLH.
偶联物
形式
Liquid
浓度
7.2 mg/mL
纯化类型
Protein G
保存液
PBS
内含物
0.09% sodium azide
保存条件
-20°C
运输条件
Ambient (domestic); Wet ice (international)
靶标信息
Teicoplanin is a glycopeptide antibiotic produced by the actinobacterium Actinoplanes teichomyceticus, primarily used to treat severe infections caused by multidrug-resistant Gram-positive pathogens. Structurally, teicoplanin consists of a complex of five closely related glycopeptides sharing a heptapeptide base and an aglycone with aromatic amino acids, d-mannose, and N-acetyl-d-glucosamine, with a molecular weight ranging from 1562 to 1891 Da. It is structurally similar to vancomycin and functions by inhibiting bacterial cell wall synthesis, making it effective against various Gram-positive bacteria. Teicoplanin has been explored for its potential use in treating COVID-19 due to its ability to inhibit the viral life cycle of coronaviruses, including SARS-CoV-2.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
篇参考文献 (0)
您是否在文献中引用过该产品？请点击下方按钮邮件告知我们。
